Satsuma Pharmaceuticals Inc. (STSA) NASDAQ

$4.25 -0.05 (-1.16%)

Market Cap: $135.65M

As of 06/28/22 04:00 PM EDT. Market closed.

(STSA)

Satsuma Pharmaceuticals Inc. (STSA) NASDAQ

$4.25 -0.05 (-1.16%)

Market Cap: $135.65M

As of 06/28/22 04:00 PM EDT. Market closed.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, ... read more

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, nasal delivery device. DHE products have long been recommended as a first-line therapeutic option for the acute treatment of migraine and have significant advantages over other therapeutics for many patients. However, broad use has been limited by invasive and burdensome administration and/or sub-optimal clinical performance of available injectable and liquid nasal spray products. STS101 is in Phase 3 development and specifically designed to deliver the clinical advantages of DHE while overcoming these shortcomings. read less

COMPANY PROFILE
Sector
Industry
CEO
John Kollins
Full Time Employees
19
URL
Address
400 Oyster Point Blvd Ste 221, California, South San Francisco, 94080-1952.
Sector
Industry
CEO
John Kollins
Full Time Employees
19
Address
400 Oyster Point Blvd Ste 221, California, South San Francisco, 94080-1952.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$4.38
Previous Close
$4.30
Days Range
$4.20 - $4.54
52 week range
$2.51 - $7.46
Volume
17,563
Avg. Volume (30 days)
102,119
Market Cap
$135.65M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,545,564
Open
$4.38
Previous Close
$4.30
Days Range
$4.20 - $4.54
52 week range
$2.51 - $7.46
Volume
17,563
Avg. Volume (30 days)
102,119
Market Cap
$135.65M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,545,564

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SATSUMA PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
COMMODORE CAPITAL LP 10% Owner Nov 24, 2021 Buy $5.42 2,922 15,837 3,711,286 Nov 29, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Nov 22, 2021 Buy $5.49 9,979 54,785 3,708,364 Nov 23, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Nov 19, 2021 Buy $5.44 3,225 17,544 3,698,385 Nov 23, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Nov 11, 2021 Buy $6.05 7,941 48,043 3,695,160 Nov 12, 2021, 04:31 PM
COMMODORE CAPITAL LP 10% Owner Nov 10, 2021 Buy $5.85 9,622 56,289 3,687,219 Nov 12, 2021, 04:31 PM
COMMODORE CAPITAL LP 10% Owner Nov 08, 2021 Buy $5.99 560 3,354 3,677,597 Nov 10, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Nov 05, 2021 Buy $5.95 7,800 46,410 3,677,037 Nov 08, 2021, 04:33 PM
COMMODORE CAPITAL LP 10% Owner Nov 04, 2021 Buy $5.88 1,400 8,232 3,669,237 Nov 08, 2021, 04:33 PM
COMMODORE CAPITAL LP 10% Owner Nov 02, 2021 Buy $5.64 8,880 50,083 3,667,837 Nov 04, 2021, 04:31 PM
COMMODORE CAPITAL LP 10% Owner Oct 29, 2021 Buy $5.71 44,651 254,957 3,658,957 Nov 02, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Oct 28, 2021 Buy $5.55 15,082 83,705 3,614,306 Oct 29, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Oct 27, 2021 Buy $5.45 39,581 215,716 3,599,224 Oct 29, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Oct 22, 2021 Buy $5.51 27,629 152,236 3,559,643 Oct 25, 2021, 04:31 PM
COMMODORE CAPITAL LP 10% Owner Oct 21, 2021 Buy $5.40 32,816 177,206 3,532,014 Oct 25, 2021, 04:31 PM
COMMODORE CAPITAL LP 10% Owner Oct 20, 2021 Buy $5.44 40,663 221,207 3,499,198 Oct 21, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Oct 19, 2021 Buy $5.07 87,580 444,031 3,458,535 Oct 21, 2021, 04:30 PM
COMMODORE CAPITAL LP 10% Owner Oct 18, 2021 Buy $4.87 36,194 176,265 3,370,955 Oct 19, 2021, 05:13 PM
COMMODORE CAPITAL LP 10% Owner Oct 15, 2021 Buy $4.83 126,000 608,580 3,334,761 Oct 19, 2021, 05:13 PM
RA CAPITAL MANAGEMENT, L.P. Director Feb 26, 2021 Buy $5.68 1,232,394 6,999,998 5,155,854 Mar 02, 2021, 04:30 PM
ALBRECHT DETLEF Chief Medical Officer Sep 01, 2020 Option Exercise $4.56 1,000 4,560 21,212 Sep 03, 2020, 04:06 PM
ALBRECHT DETLEF Chief Medical Officer Sep 01, 2020 Sale $22.21 1,000 22,210 20,212 Sep 03, 2020, 04:06 PM
O'Neil Thomas P. Chief Financial Officer Sep 01, 2020 Option Exercise $4.56 750 3,420 750 Sep 03, 2020, 04:05 PM
O'Neil Thomas P. Chief Financial Officer Sep 01, 2020 Sale $22.19 750 16,645 0 Sep 03, 2020, 04:05 PM
O'Neil Thomas P. Chief Financial Officer Aug 05, 2020 Option Exercise $4.56 1,000 4,560 1,000 Aug 07, 2020, 06:40 PM
O'Neil Thomas P. Chief Financial Officer Aug 05, 2020 Sale $25.00 1,000 25,000 0 Aug 07, 2020, 06:40 PM
ALBRECHT DETLEF Chief Medical Officer Aug 03, 2020 Option Exercise $4.56 1,000 4,560 21,012 Aug 05, 2020, 04:03 PM
ALBRECHT DETLEF Chief Medical Officer Aug 03, 2020 Sale $22.91 1,000 22,906 20,212 Aug 05, 2020, 04:03 PM
O'Neil Thomas P. Chief Financial Officer Jul 01, 2020 Option Exercise $4.56 1,000 4,560 394 Jul 02, 2020, 04:15 PM
O'Neil Thomas P. Chief Financial Officer Jul 01, 2020 Sale $26.65 1,000 26,654 0 Jul 02, 2020, 04:15 PM
ALBRECHT DETLEF Chief Medical Officer Jul 01, 2020 Option Exercise $4.56 1,000 4,560 20,812 Jul 02, 2020, 04:13 PM
ALBRECHT DETLEF Chief Medical Officer Jul 01, 2020 Sale $26.68 1,000 26,683 20,212 Jul 02, 2020, 04:13 PM
O'Neil Thomas P. Chief Financial Officer Jun 23, 2020 Option Exercise $1.04 2,115 2,200 2,115 Jun 24, 2020, 04:53 PM
O'Neil Thomas P. Chief Financial Officer Jun 23, 2020 Sale $35.23 2,115 74,512 0 Jun 24, 2020, 04:53 PM
ALBRECHT DETLEF Chief Medical Officer Jun 01, 2020 Option Exercise $4.56 1,000 4,560 21,212 Jun 02, 2020, 07:33 PM
ALBRECHT DETLEF Chief Medical Officer Jun 01, 2020 Sale $25.26 1,000 25,257 20,212 Jun 02, 2020, 07:33 PM
O'Neil Thomas P. Chief Financial Officer Jun 01, 2020 Option Exercise $4.56 1,000 4,560 1,000 Jun 02, 2020, 07:31 PM
O'Neil Thomas P. Chief Financial Officer Jun 01, 2020 Sale $25.32 1,000 25,323 0 Jun 02, 2020, 07:31 PM
O'Neil Thomas P. Chief Financial Officer May 20, 2020 Option Exercise $4.56 2,000 9,120 2,000 May 21, 2020, 05:34 PM
O'Neil Thomas P. Chief Financial Officer May 20, 2020 Sale $25.00 2,000 50,000 0 May 21, 2020, 05:34 PM
ALBRECHT DETLEF Chief Medical Officer May 05, 2020 Option Exercise $4.56 1,000 4,560 21,212 May 06, 2020, 07:47 PM
ALBRECHT DETLEF Chief Medical Officer May 05, 2020 Sale $20.00 1,000 20,000 20,212 May 06, 2020, 07:47 PM
ALBRECHT DETLEF Chief Medical Officer Apr 14, 2020 Option Exercise $4.56 800 3,648 21,012 May 06, 2020, 07:46 PM
ALBRECHT DETLEF Chief Medical Officer Apr 14, 2020 Sale $20.00 800 16,000 20,212 May 06, 2020, 07:46 PM
ALBRECHT DETLEF Chief Medical Officer Apr 01, 2020 Option Exercise $4.56 200 912 20,412 May 06, 2020, 07:45 PM
ALBRECHT DETLEF Chief Medical Officer Apr 01, 2020 Sale $20.25 200 4,049 20,212 May 06, 2020, 07:45 PM
ALBRECHT DETLEF Chief Medical Officer Apr 14, 2020 Option Exercise $4.56 800 3,648 20,812 Apr 16, 2020, 04:12 PM
ALBRECHT DETLEF Chief Medical Officer Apr 14, 2020 Sale $20.00 800 16,000 20,012 Apr 16, 2020, 04:12 PM
ALBRECHT DETLEF Chief Medical Officer Apr 01, 2020 Option Exercise $4.56 200 912 20,412 Apr 03, 2020, 04:11 PM
ALBRECHT DETLEF Chief Medical Officer Apr 01, 2020 Sale $20.25 200 4,049 20,012 Apr 03, 2020, 04:11 PM
ALBRECHT DETLEF Chief Medical Officer Mar 11, 2020 Option Exercise $4.56 1,000 4,560 21,212 Mar 12, 2020, 05:32 PM
ALBRECHT DETLEF Chief Medical Officer Mar 11, 2020 Sale $27.42 1,000 27,422 20,212 Mar 12, 2020, 05:32 PM
O'Neil Thomas P. Chief Financial Officer Mar 11, 2020 Option Exercise $4.56 1,000 4,560 1,000 Mar 12, 2020, 05:31 PM
O'Neil Thomas P. Chief Financial Officer Mar 11, 2020 Sale $27.68 1,000 27,678 0 Mar 12, 2020, 05:31 PM
TPG Group Holdings (SBS) Advisors, Inc. 10% Owner Sep 17, 2019 Buy $15.00 100,000 1,500,000 1,885,939 Sep 18, 2019, 04:40 PM
RA CAPITAL MANAGEMENT, LLC Director Sep 17, 2019 Buy $15.00 1,333,333 19,999,995 4,681,858 Sep 17, 2019, 05:04 PM
Shah Rajeev M. Director Sep 17, 2019 Buy $15.00 1,333,333 19,999,995 4,681,858 Sep 17, 2019, 04:05 PM
TAKANASHI KEN Director Sep 17, 2019 Buy $15.00 233,333 3,499,995 1,561,719 Sep 17, 2019, 04:05 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
COMMODORE CAPITAL LP 10% Owner 11/24/2021 15,837
COMMODORE CAPITAL LP 10% Owner 11/22/2021 54,785
COMMODORE CAPITAL LP 10% Owner 11/19/2021 17,544
COMMODORE CAPITAL LP 10% Owner 11/11/2021 48,043
COMMODORE CAPITAL LP 10% Owner 11/10/2021 56,289
COMMODORE CAPITAL LP 10% Owner 11/08/2021 3,354
COMMODORE CAPITAL LP 10% Owner 11/05/2021 46,410
COMMODORE CAPITAL LP 10% Owner 11/04/2021 8,232
COMMODORE CAPITAL LP 10% Owner 11/02/2021 50,083
COMMODORE CAPITAL LP 10% Owner 10/29/2021 254,957
COMMODORE CAPITAL LP 10% Owner 10/28/2021 83,705
COMMODORE CAPITAL LP 10% Owner 10/27/2021 215,716
COMMODORE CAPITAL LP 10% Owner 10/22/2021 152,236
COMMODORE CAPITAL LP 10% Owner 10/21/2021 177,206
COMMODORE CAPITAL LP 10% Owner 10/20/2021 221,207
COMMODORE CAPITAL LP 10% Owner 10/19/2021 444,031
COMMODORE CAPITAL LP 10% Owner 10/18/2021 176,265
COMMODORE CAPITAL LP 10% Owner 10/15/2021 608,580
RA CAPITAL MANAGEMENT, L.P. Director 02/26/2021 6,999,998
ALBRECHT DETLEF Chief Medical Officer 09/01/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 09/01/2020 22,210
O'Neil Thomas P. Chief Financial Officer 09/01/2020 3,420
O'Neil Thomas P. Chief Financial Officer 09/01/2020 16,645
O'Neil Thomas P. Chief Financial Officer 08/05/2020 4,560
O'Neil Thomas P. Chief Financial Officer 08/05/2020 25,000
ALBRECHT DETLEF Chief Medical Officer 08/03/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 08/03/2020 22,906
O'Neil Thomas P. Chief Financial Officer 07/01/2020 4,560
O'Neil Thomas P. Chief Financial Officer 07/01/2020 26,654
ALBRECHT DETLEF Chief Medical Officer 07/01/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 07/01/2020 26,683
O'Neil Thomas P. Chief Financial Officer 06/23/2020 2,200
O'Neil Thomas P. Chief Financial Officer 06/23/2020 74,512
ALBRECHT DETLEF Chief Medical Officer 06/01/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 06/01/2020 25,257
O'Neil Thomas P. Chief Financial Officer 06/01/2020 4,560
O'Neil Thomas P. Chief Financial Officer 06/01/2020 25,323
O'Neil Thomas P. Chief Financial Officer 05/20/2020 9,120
O'Neil Thomas P. Chief Financial Officer 05/20/2020 50,000
ALBRECHT DETLEF Chief Medical Officer 05/05/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 05/05/2020 20,000
ALBRECHT DETLEF Chief Medical Officer 04/14/2020 3,648
ALBRECHT DETLEF Chief Medical Officer 04/14/2020 16,000
ALBRECHT DETLEF Chief Medical Officer 04/01/2020 912
ALBRECHT DETLEF Chief Medical Officer 04/01/2020 4,049
ALBRECHT DETLEF Chief Medical Officer 04/14/2020 3,648
ALBRECHT DETLEF Chief Medical Officer 04/14/2020 16,000
ALBRECHT DETLEF Chief Medical Officer 04/01/2020 912
ALBRECHT DETLEF Chief Medical Officer 04/01/2020 4,049
ALBRECHT DETLEF Chief Medical Officer 03/11/2020 4,560
ALBRECHT DETLEF Chief Medical Officer 03/11/2020 27,422
O'Neil Thomas P. Chief Financial Officer 03/11/2020 4,560
O'Neil Thomas P. Chief Financial Officer 03/11/2020 27,678
TPG Group Holdings (SBS) Advisors, Inc. 10% Owner 09/17/2019 1,500,000
RA CAPITAL MANAGEMENT, LLC Director 09/17/2019 19,999,995
Shah Rajeev M. Director 09/17/2019 19,999,995
TAKANASHI KEN Director 09/17/2019 3,499,995
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
2.80%
1Q
12/31/2021
06/30/2021
8.95%
2Q
12/31/2021
03/31/2021
32.76%
3Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
2.80%
1Q
06/30/2021
8.95%
2Q
03/31/2021
32.76%
3Q